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Trypanosomiasis, a protozoan disease affecting livestock and transmitted by Glossina (tsetse) flies is a 
major constraint to livestock production in Sub-Saharan Africa. Approaches towards developing an 
anti-trypanosomal vaccine have so far shown little success. This study is targeted towards assessing the 
prophylactic potential of a “trypanotolerant” rabbit anti-serum vaccine in the presence or absence of an 
adjuvant (peanut oil) in the course of Trypanosoma congolense infection in mice. Forty healthy female 
Swiss albino mice were grouped in eight (n=5) as follows: unimmunized uninfected, serum-
immunized uninfected, adjuvant-immunized uninfected, serum-adjuvant immunized uninfected, 
unimmunized infected, serum-immunized infected, adjuvant-immunized infected, serum-adjuvant 
immunized infected. For the first immunization, 200 μg of crude rabbit antiserum emulsified in a 100μl 
of phosphate-buffered saline (PBS) and adjuvant (1:1) or 200 μg of crude rabbit antiserum was injected 
intramuscularly on day 0. Similarly, the mice were administered a booster of half the crude antiserum 
(100 μg) every two weeks three consecutive times. Each mouse in the infected groups received 200μl 
of infective donor mouse blood containing 1x106 Trypanosomes per ml of blood on day 42 post 
immunization. Blood samples were collected daily for parasitemia determination and on days 0, 42 and 
62 post immunization for hematological parameters determination. The pre-patent periods, body 
weight changes and survival times were assessed as well. Immunization with the rabbit antiserum 
(emulsified with or without the adjuvant) resulted in significantly (P<0.05) lowered mean parasitemia 
levels. However, significant (P<0.05) increases were observed in the mean pre-patent periods, body 
weights, survival times, red blood cell counts and differential white blood cell counts in the serum and 
serum-adjuvant immunized groups. Results from this study have shown some promising effectiveness 
of antiserum prophylaxis when used alongside an adjuvant (peanut oil) during the course of 
Trypanosoma congolense infection in experimental mice. 
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African trypanosomiasis is an infectious 
disease of humans and animals of similar 
aetiology and epidemiology. The causative 
agents of the disease are protozoan parasites of 
the genus Trypanosoma that live and multiply 
extracellularly in blood and tissue fluids of 
their mammalian hosts and are transmitted by 
the bite of infected tsetse flies (Glossina spp.).  
African animal trypanosomiasis or nagana 
disease is caused by T. congolense, T. vivax and 
T. brucei species. In wild animals, these 
parasites cause relatively mild infections while 
in domestic animals they cause a severe, often-
fatal disease. All domestic animals can be 
affected by nagana and the symptoms are fever, 
listlessness, emaciation, hair loss, discharge 
from the eyes, oedema, anaemia, and paralysis. 
Other symptoms include lymphoid 
enlargement, loss of condition and 
immunosuppression with reduced host 
resistance to secondary infections (Darji et al., 
1992).  
 
Control of trypanosomiasis is based primarily 
on insecticide spraying to control tsetse 
populations and on regular treatment of 
livestock at risk with trypanocidal drugs. 
However, has complete control been achieved 
using these methods, even after substantial 
effort. The high cost of regular drug and 
insecticidal treatment, the limited effectiveness 
of insecticide application in high-rainfall areas, 
the possibility of environmental pollution by 
insecticides, the increasing incidence of 
parasite resistance to available drugs and the 
absence of new drugs to replace them are some 
of the problems that make tsetse and 
trypanosomiasis control difficult and expensive 
(WHO, 2005). 
Other methods for controlling trypanosomiasis 
rely on the use of indigenous livestock such as 
N’Dama and other West African cattle breeds 
that are able to tolerate infection by 
trypanosomes. This genetic ability to resist 
pathogenic effects of infection is called 
trypanotolerance.  The use of trypanotolerant 
breeds makes livestock rearing possible in 
areas where the presence of tsetse flies infected 
with trypanosomes preclude the production of 
animals that are susceptible to the disease 
(Murray et al., 1990).  
All attempts to produce vaccines against 
African trypanosomes were only partially 
successful or failed completely due to antigenic 
variation that has rendered the prospect of a 
plausible vaccine forlorn (Chechet et al., 2010; 
Magez et al., 2010).  
Successful vaccination against a pathogen 
depends on the development in the host of a 
protective immune response that either 
neutralizes the effects of the pathogen or 
destroys it. When an animal is infected with 
trypanosomes, it produces immune responses to 
parts of the parasites. However, the immune 
responses in humans and most livestock types 
are unable to eliminate the parasites or even 
reduce parasite numbers to tolerable levels. The 
reason for this is that the trypanosome is able to 
change the molecules on its surface to which an 
animal’s immune responses are normally 
directed (Field et al., 2009). 
Research results have shown that resistant 
animals such as the N’Dama cattle produce 
much better antibody responses to some 
components of the parasite than susceptible 
animals. The generation of antibodies to these 
parasite components appears to correlate with 
an ability to overcome infections. This 
correlation has significance for potential 
vaccine development (Silva et al., 2009).  
Adjuvants are essential immunostimulatory 
substances to stimulate the immunogenic 
response to antigens with low immunogenicity. 




Freund´s adjuvant has been widely used over 
the years in experimental models, but the 
severity of its side effects have limited its use 
in vaccines for human beings and other animals 
(Gupta et al., 1993). Therefore, the 
development of new adjuvants is essential, not 
only on improving the low immunogenicity of 
purified antigens but also their promising 
influence on DNA vaccines (Sesardic and 
Dobbelaer, 2004) 
In this study, we showed the immunogenic 
effect of emulsions prepared with 
trypanotolerant rabbit antiserum and peanut oil 
during the course of Trypanosoma congolense 
infection in experimentally infected mice.  
 
MATERIALS AND METHODS 
Parasites 
T. congolense was isolated from an infected 
cow at an abattoir in Kaduna State, Nigeria and 
was characterized in the DFG laboratory at the 
Centre for Biotechnology Research and 
Training, Ahmadu Bello University, Zaria and 
passaged into albino rats. Cyclical transmission 
from tsetse flies to goats and serial passages in 
rats was used to maintain the parasites. 
 
Parasite Authentication by Polymerase 
Chain Reaction (PCR)  
Polymerase Chain Reaction (PCR) was 
performed using Phusion Blood direct kit 
(Finzymes) and ITS-1 generic primers to 
further authenticate the identity of the parasites. 
Briefly, 1µl of blood from an infected animal 
was included in the first round of PCR. The 
PCR was performed in a 20µl reaction volume 
containing 10µl of the Phusion buffer 
(Finzymes), 1.0µl of each outer primer (10 
µM), 0.4µL of Phusion enzyme, 6.6µL of 
double distilled water and 1µL of blood that 
served as template in the first reaction. The 
cycling conditions were as follows: 1 cycle at 
980C for 300 seconds followed by 35 cycles at 
980C for 1 second, 570C for 5 seconds, 720C for 
20 seconds and a final extension at 720C for 60 
seconds. At the end of the reaction, the tubes 
were centrifuged at 1800 rpm for 3 minutes and 
1µL of the supernatant was used as template in 
the second reaction. Nested PCR was 
performed using a 25µL reaction volume 
containing 1µL (1ng/µL) template DNA, 25µM 
of each primer, 10mM dNTPs, 25mM 10x 
Dream Taq polymerase buffer, 5U/µL Dream 
Taq polymerase to a reaction volume of 25µL. 
Cycling conditions were as follows: 1 cycle at 
950C for 300 seconds followed by 30 cycles at 
950C for 60 seconds, 560C for 60 seconds, 720C 
for 30 seconds, and final extension 720C for 
220 seconds. The products were resolved by 
electrophoresis (45 minutes to 1 hour at 100V) 
on 1.0% Agarose gels stained with G-Stain 
(Serva®) and bands were visualized using 
GelDoc-It2 Imaging System (Analytik Jena AG 
Jena, Germany). 
Rabbit Serum 
Serum used for immunization studies was 
obtained from a rabbit originally infected with 
a combination of T.congolense and T.b.brucei. 
After a period of time, T.congolense parasites 
were cleared from circulation and leaving 
T.b.brucei. The rabbit displayed waves of 
parasitemia and all clinical symptoms of 
Trypanosomiasis. Interestingly, the rabbit 
showed signs of recuperation after the 10 
months period it survived the infection.  
Experimental Animals 
Forty healthy female Swiss albino mice of 
approximately 4 weeks old weighing between 
12-26g were purchased from the National 
Institute of Trypanosomiasis Research, 
Kaduna. They were kept in cages lined with 
wood shavings and cleaned twice a week. The 
cages were also provided with water bottles to 
supply drinking water ad libitum to the mice. 
The mice were fed regularly with standard rat 
pallets. They were allowed to acclimatize for a 




period of 2 weeks before the commencement of 
the experiment. 
 
Determination of Parasitemia 
Parasite count was determined microscopically 
at x40 magnification using the “Rapid 
Matching” method of Herbert and Lumsden 
1976. Briefly, the method involves microscopic 
counting of parasites per field in pure blood or 
blood appropriately diluted with phosphate 
buffered saline (PBS, pH 7.4). Logarithmatric 
values of these counts obtained by matching 
with the table of Herbert and Lumsden (1976) 
is converted to antilog to provide absolute 




The mice were grouped randomly into 8 groups 
of 5 mice each as follows: Group 1-
unimmunized uninfected, Group 2- serum-
immunized uninfected, Group 3- adjuvant-
immunized uninfected, Group 4- serum-
adjuvant immunized uninfected, Group 5- 
unimmunized infected, Group 6- serum-
immunized infected, Group 7- adjuvant-
immunized infected, Group 8- serum-adjuvant 
immunized infected. All the groups of 
immunized mice received intramuscular 
injection in each thigh muscle of either rabbit 
serum (200µg/100µl), adjuvant (Arachis oil) 
100µl, both in an equal ratio (50µl serum: 50µl 
adjuvant) or PBS on day 0 post immunization. 
Half the amount of serum (100 µg/100µl) was 
used to immunize the mice on day 14 and 28 
post immunization. On day 42, all animals in 
the infected groups were infected by intra-
peritoneal injection with 1x106 savannah strain 
of T. congolense. Blood was collected in EDTA 
tubes at three different time intervals (Day 0, 
42 and 62 representing pre-immunization, post-
immunization and post-infection times 
respectively). 
Determination of Hematological Parameters 
Blood was collected at three different time 
intervals via each mouse-tail into EDTA tubes. 
Hematological analysis was performed using 
standard protocols. Differential leucocyte 
counts and Red Blood Cell (RBC) counts were 
determined manually employing an improved 
Haemocytometer. For the determination of 
differential leucocyte counts, Giemsa-stained 
thin blood smears were prepared and the 
number of cells per slide (usually 100 cells), 
the shape of the nucleus as well as the presence 
or absence of granules in their cytoplasm. The 
relative numbers of monocytes, basophils, 
neutrophils, eosinophils, lymphocytes and 
leukocytes were expressed as percentages and 
calculated as:  
%=Number of cells inside differential cell 
area/Number of cells in total cell area x 100 
Whereas, RBC counts in turn were expressed 
as number of cells per microliter of blood.  
 
Determination of Body Weight 
The weight of each animal was carefully 
determined using a digital weighing balance. 
The weights of the animals were taken at three 
intervals during the course of the experiment; 
pre-immunization which served as the baseline 
the baseline, post immunization and post 
infection.  
Determination of Survival  
Animal survival was determined daily post-
infection and the mean survival time was 




All data were expressed as means ± standard 
deviation of five measurements using Graph 
Pad Prism 7 software Version 7.0a. One-way 
ANOVA was used to assess the differences in 
pre-patent period. Two-way ANOVA was used 
to assess body weight as well as the 
hematological parameters. The level of 








Pre-patent Period, Parasitemia and Survival 
Assessment 
Species-specific primers were used to amplify 
the ITS-1 region of the gDNA and a strong 
band was produced at 850bp while the negative 




Figure 1: PCR identification of T. congolense using 
species-specific primers. The PCR products were 
analyzed by the electrophoresis on a 1.0% Agarose 
gel stained with G-Stain. M-Marker, Lane 1,2,3 -
gDNA from T.congolense infected mice,-ve – 
nNegative control with water 
 
 
Findings on the unimmunized infected group 
had a mean pre-patent period of 10.6±1.14 
days. While animals immunized with serum-
adjuvant, adjuvant alone and serum alone had 
mean pre-patent periods of 16.8±1.48, 
9.4±1.14, 11±0.71 days post infection 
respectively as shown in figure 1. The pre-
patent periods of the immunized adjuvant alone 
and serum alone were not significantly 
different (P>0.05) from that of the 
unimmunized infected group. The 
unimmunized infected and adjuvant groups 
developed parasitemia of 0.05±1.12 
parasites/ml on days 9 and 8 respectively while 
the serum and serum-adjuvant immunized 
groups developed parasitemia of 0.10 ±1.37 
parasites/ml each on days 11 and 17 
respectively (Figure 2). The mean parasitemia 
peaked at 6.95±3.34 parasites/ml on day 20 for 
the unimmunized infected group while the 
mean parasitemia peaked at 5.02±1.79 
parasites/ml on day 23 for the adjuvant-
immunized group. However, for the adjuvant-
immunized group, the mean parasitemia peaked 
0.31±0.11 parasites/ml on day 22, declined to 
0.05±1.12 parasites/ml on day 23 but increased 
to 0.20±1.12 parasites/ml on day 24 and peaked 
at 1.38±1.89 parasites/ml on day 31. On the 
other hand, the serum-adjuvant immunized 
group peaked at 0.28±0.11 parasites/ml on day 
24, declined the level where no parasites were 
observed on day 28 but parasitemia resurfaced 
on day 29 which increased and peaked on day 
40 at 0.97±1.03 parasites/ml (Figure 2).  
 
 






















































































Figure 2: Mean pre-patent periods (days) of  
immunized and unimmunized infected groups  
of experimental mice. 
 
Animal Survival and Body Weight 
Mice in the unimmunized and adjuvant-
immunized groups survived until days 13 and 
16 respectively, after which they started to die. 
60% of the animals from the same group 
survived until days 15 and 18 respectively, 
after which they all died at 21 and 24 days 
respectively. In contrast, animals in the serum 
and serum-adjuvant immunized groups 
survived until days 22 and 33 respectively 
before they started dying and 50% of them 
survived until day 28 and 38 respectively. 20% 
of the mice in both groups survived after 30 
and 40 days respectively (Figure 3). Mean 
weight loss was shown to be more pronounced 
in the infected groups and highest in animals of 
the unimmunized untreated 18.2±1.48 and was 
statistically insignificant (P>0.05) when 
compared to mean weight of animals (at the 
termination of the experiment) in the serum-
immunized 18.8±2.49 and serum-adjuvant 
immunized groups 20.4±2.30 (Figure 4). Also, 
a decrease in mean weight of 21.4±2.30 to 
18.8±2.49 was also observed in animals of the 
serum-immunized as well as in serum-adjuvant 
immunized group from 24.00±1.00 to 
20.4±2.30. In contrast, a steady increase in 
body weight was observed in the uninfected 
groups throughout the duration of the 
experiment. 
Hematological Parameters 
Findings showed there was no significant 
difference (P>0.05) in mean RBC count 
between the infected and uninfected groups 
before and after immunization (Figure 6). 
However, after infection, there was no 
significant difference (P>0.05) in mean RBC 
count between the unimmunized infected group 
with adjuvant-immunized groups. However, 
there was a significant difference (P<0.05) in 
mean RBC counts between the unimmunized 
infected, serum and serum-adjuvant immunized 
groups. Similarly, there was a significant 
reduction in RBC count between the serum and 
serum-adjuvant immunized groups but none 
was observed between the serum immunized 
and adjuvant immunized or serum-adjuvant 
immunized groups.  
The mean differential WBC count indicated 
that the basophils, eosinophils, monocytes 
neutrophils and lymphocytes fluctuated within 
control levels in all groups during the pre and 
post immunization periods of the experiment 
(Figures 7-11). Significant (P<0.05) decreases 
in the mean differential WBC counts were 
observed in the animals of the infected 
immunized groups post infection and did not 
return to basal level when compared with the 
unimmunized infected group of animals. On the 
contrary, significant (P<0.05) monocytosis was 
observed in the infected group being most 
prominent in the unimmunized and adjuvant-
immunized infected groups post infection. 




Notably, animals in the unimmunized and 
adjuvant-immunized infected groups 
consistently showed the most depressed mean 
differential WBC counts (besides monocytes 
count) post infection when compared to 
animals in the other infected groups while the 
serum-adjuvant immunized group showed the 
highest elevation.  
 
 












































Figure 3: Mean parasitemia of immunized and  
unimmunized infected groups of experimental  
mice. 
 






















Figure 4: Kaplan-Meier mean survival plots  
for the immunized and unimmunized infected  





Mixed infections of trypanosomes occur in the 
field. Therefore, the precise identification of 
species used in experiments is essential for 
understanding the epidemiology and 
pathogenesis of these parasites (Gibson, 2007). 
Thus, it was imperative to detect the right 
Trypanosoma congolense specie used in this 
study. Microscopy has been the gold standard 
tool available for detection and identification of 
parasites in blood and other biological samples 
(Tanowitz et al., 1992; Herwaldt, 1999; 
Melrose et al., 2004; Duffy and Fried, 2005; 
Costa-juniour et al., 2012). Although this 
inexpensive diagnostic test has been proven 
sometimes, to be insensitive, inaccurate, 
despite its being inexpensive (Böse et al., 1995; 
Costa-juniour et al., 2012). We therefore 
employed a PCR-based approach that is 
sensitive and reliable for detecting and 
identifying various trypanosome species in 
blood through amplification of the ITS-1 region 
using two primer sets, which gave a unique 




product size of 850bp for T.congolense 
savannah (Adams et.al., 2006).  
From the results of this study we have 
demonstrated that immunizing Swiss albino 
mice challenged with of T. congolense (1x106) 
with serum of a trypanotolerant rabbit 
conferred some form of protection on the 
immunized-infected groups of mice. This was 
observed in the extended pre-patent period and 
decreased parasitemia levels observed in the 
groups immunized with serum and serum-
adjuvant when compared to the groups that 
were immunized with the adjuvant only or non-
immunized groups. The pre-patent period as 
well as parasitemia was observed to be 
extended in the serum-adjuvant immunized 
group compared to the serum immunized 
group.  
A decreased RBC count was observed in 
infected mice even though the decline was most 
prominent in the unimmunized as well as the 
adjuvant-immunized groups. Anemia, which is 
the hallmark of trypanosomiasis infection 
(Noyes et al., 2009), is usually characterized by 
a decreased red blood cell count. Studies have 
suggested that galectin-3 (Gal-3) and 
macrophage migration inhibitory factor (MIF) 
possibly could be operating in concert with 
TNF-α during the development of anemia. 
While Gal-3 elevates erythrophagocytosis, MIF 
bolsters both myeloid cell recruitment and iron 
retention within the Mononuclear Phagocyte 
System (MPS), thereby divesting iron for 
erythropoiesis. Thus, the concomitant 
enhancement of erythrophagocytosis and 
suppression of erythropoiesis eventually leads 
to anemia (Stijlemans et al., 2018).  
Besides anemia, another remarkable trait of 
African animal trypanosomiasis is immune 
system suppression of the infected mammalian 
host. Generation of macrophages that suppress 
both antibody mediated immunity (B cells) and 
cellular immunity (T cells) as well as 
polyclonal activation of B cells have both been 
hypothesized to account for 
immunosuppression during trypanosome 
infection in mice (Ademola and Odeniran, 
2016). 
Decreased numbers of basophils, eosinophils, 
neutrophils as well as lymphocytes were 
observed in the unimmunized infected groups 
post-infection when compared with the 
uninfected groups. In contrast, an elevated 
monocyte level was recorded in the infected 
groups. Our results corroborate the findings of 
Ademola and Odeniran (2016) and Dagnachew 
et al., (2015) who reported Leucopaenia, 
thrombocytopenia, lymphopaenia, 
neutropaenia, pancytopenia and monocytosis 
associated with T.b.brucei, T.congolense and 
T.vivax infections in mice and cattle. On the 
contrary, a consistent elevated level of the 
differential WBC counts (besides the 
monocytes) was observed in the immunized 
infected groups. These results suggest that the 
serum could actually have conferred some 
protection on the immunized infected animals 
and more so on animals that received the 
combination of serum and adjuvant which is 
seen by the boosts in differential WBC counts 
observed in the immunized infected groups. 
Neutrophils are among the first immune cells to 
travel to the infection site and are important in 
controlling the host defense through oxidant 
and protease-dependent mechanisms 
(Faurschou and Borregaard, 2003; Laskay et 
al., 2003; Nauseef, 2007). These cells also 
provide an important link between innate and 
adaptive immunity during parasite infections 
(Appelberg, 2007; Nathan, 2006). Similarly, 
Eosinophils are components of the immune 
system that fight multicellular parasites and are 
most often regarded as indicators of parasitic 
infections. Gleich and Adolph (1986) 
demonstrated, the participation of eosinophils 
in host defense mechanisms to helminth 




infection and the in-vitro killing of various 
parasites by eosinophils from different species 
while Nakhle et al., (1989) demonstrated the 






































Figure 5: Mean body weight for the 
 immunized and unimmunized infected and  

























































Figure 6: Mean RBC count for the immunized 
and unimmunized infected and uninfected 
groups of experimental mice. 
 
In this study, we did not monitor antibodies that 
induce immunosuppression in the course of the 
infection. However, the differential WBC 
counts can give an idea with regard the immune 
responses observed in the groups of mice 
immunized with the antiserum. 
 
We could speculate that the antiserum could 
possibly be acting synergistically and in 
concert with the adjuvant and this could be 
responsible for the elevated pre-patent period, 
parasitemia, weight, survival as well as the 
RBC and differential leucocyte counts observed 
in the serum-adjuvant immunized infected 
group but not in the serum-immunized infected 
group. Clearly, the adjuvant immunized 
infected groups did not differ significantly from 
the unimmunized infected group 
 
 
































































Figure 7: Mean Basophils for the immunized  
and unimmunized infected and uninfected  






























































Figure 8: Mean Eosinophils for the immunized 
 and unimmunized infected and uninfected  
groups of experimental mice. 
 




























































Figure 9: Mean Monocytes for the immunized  
and unimmunized infected and uninfected  


























































Figure 10: Mean Neutrophils for the 
 immunized and unimmunized infected and  
uninfected groups of experimental mice. 
 
 





























































Figure 11: Mean Lymphocytes for the 
 immunized and unimmunized infected and  




Antiserum is whole serum from blood of 
human or animals inoculated with an antigenic 
material or from those that recovered from a 
disease when they naturally developed certain 
antibodies against particular antigens that 
contains increased polyclonal IgG & IgM 
concentration to the specific immunogen 
including lots of other antibody specificities. 
Antisera are prepared to combat certain 
diseases. They are in particular used to provide 
passive immunity against diseases. The binding 
of antibodies to the antigens stimulates the 
immune system to carry out a stronger immune 
response against the antigen.  
 
Adjuvants on the other hand are important tools 
required in slowly releasing antigens to 
stimulate the creation of antibodies (Petrovsky 
and Aguilar, 2004). Adjuvants may be added to 
a vaccine/immunogen to modify the immune 
system’s response to the target antigen by 
boosting it such as to give a higher amount of 
antibodies and a longer-lasting protection but 
themselves do not provide immunity. 
Vegetable oils have been shown to be potential 
immunological adjuvants and have been shown 
to elicit humoral and cellular responses (Silva, 
2004; Feijó, 2005; Sartor et al., 2011). An 
outstanding leverage of vegetable oils is that 
they have minimal adverse side-effects for 
being biodegradable compounds (Ehhafona, 
1996) The potentiality of the usage of peanut 
oil and other vegetable oils as adjuvant of the 
humoral and cellular immune response induced 
by Leshmenia antigens has been recently 
shown (Freitas et al., 2013). The peanut oil 
significantly increased the synthesis of anti-
ovalbumin antibodies in the primary response, 
even though it did not favor cellular response. 
It was observed that the mice immunized with 
Leshmenia amazonensis antigens emulsified 
with peanut oil worsened the appearance of 
skin lesions and intensified lymph node 
parasite load suggesting stimulation of the Th2 
immune response and down regulation of Th1 
response (Freitas et al., 2013). This poor 
performance could not be unrelated to the 
variety of peanuts from which the oil was 
extracted and it could perform as a better 
adjuvant against other parasite antigens.  
 
CONCLUSION 
The data obtained in the present study showed 
that the serum and serum-adjuvant immunized 
infected groups survived for longer period of 
days than the unimmunized and adjuvant-




immunized infected groups. A delay in the on-
set of parasitemia, display of parasitemia-wave 
as well as low parasitemia level accompanied 
by increased survivability of mice was 
observed in the serum and serum-adjuvant 
immunized infected groups. However, contrary 
observations were made in the unimmunized 
and adjuvant-immunized infected groups. 
Although some questions may be generated 
from the results presented in this work 
regarding, dosage of antiserum administered, 
time intervals between priming and boosting, 
route of administration and general mechanism 
of action of the antiserum since we did not 
monitor antibodies that induce 
immunosuppression in the course of the 
infection. Notwithstanding, the data generated 
shows some promising effectiveness of 
antiserum prophylaxis, which may offer some 
practical advantages when probably used in 
combination with a potential vaccine based 
regimen putting into consideration the bottle 
necks related to vaccine development strategies 
and the intrinsic mechanisms of immune 
memory development identified previously. We 
therefore recommended that some immune 
parameters be measured in order to understand 
the mechanism of immunoregulation in the 
course of the infection and also use of a more 
suitable host since the mouse-model may not be 
the most suitable representation of an optimal 
host-parasite context for the generation of 
relevant results, due to parasitaemia that may 
be a false representation of natural infections.  
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